droplet digital PCR
Bio-Rad Laboratories Q2 Revenues Decline 6 Percent, Firm Lowers Full-Year Outlook
Bio-Rad is expecting a decline in revenues for the full year due to a slower pace of recovery among customers of its core businesses.
Verily Team Finds H5 Avian Flu Subtype in Wastewater as Expanded CDC Surveillance Plan Takes Shape
Premium
The Alphabet health technology company found bird flu in Texas sewage, but CDC is not currently planning to monitor this pathogen.
Oncocyte, Bio-Rad Partner to Globally Launch Transplant Test
The test is expected to launch in Q2 2024 to select academic transplant centers in the US and EU and more broadly in the second half of the year.
Bio-Rad, Allegheny Health Network Partner for ddPCR-Based Cancer Monitoring
The collaboration will use Bio-Rad's Droplet Digital PCR technology to gather clinical data for solid tumor MRD monitoring using AHN's patient samples.
The firm expects growth in its ddPCR business this year as it launches new products and the biopharma segment begins to recover from a funding slump.
Sep 25, 2023
May 6, 2022
Oct 29, 2020
Bio-Rad Q3 Revenues Jump 15 Percent
Oct 28, 2020
Biodesix Prices $72M IPO
Apr 16, 2020
Feb 10, 2020